ATIMP trials leave little room for error. Learn how teams use contingency planning, real-time data, and AI to prevent supply disruptions.
- Decision Authority And Direction — The Gap In Deviation Planning
- Achieving Forecasting And Inventory Agility In A Volatile Clinical Trial Supply Environment
- Zen And The Art Of Comparator Supply Maintenance
- Clinical Pharmacy-Led Perspective On Clinical Trial Supply Innovation
- Inside GCSG 2026: Clinical Supply Impact On Patient Experience
- U.S. Policy Drift And The Shift In Clinical Trial Supply Leadership
- The Hidden Operational Complexities Of Home Infusion
- Building Resilient Clinical Trial Supply Chains In An Era Of Geopolitical Risk
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Avoiding The Risk Of A Non-Transparent Clinical Supply Solution
With the supply chain and transportation logistics disruption caused by the COVID-19 pandemic, full documentation and complete transparency becomes even more important to avoid delays and assert provenance.
-
Building Robust Clinical Supply Chains To Support Global Trials
Ensuring drugs reach patients at the right time and place is crucial. Review key areas to consider as you build a robust clinical supply chain that supports global trials effectively and efficiently.
-
Building Better Resilience Into Your Clinical Supply Strategy
Reliable clinical supply requires proper vendor selection, cross-functional communication, and safety nets built to accommodate an ever-changing geopolitical and global pharmaceutical landscape. To avoid supply disruptions for clinical drugs, sponsors must give clinical supply its proper weight in initial protocol development and trial design.
-
Navigating Audit Trail Data Regulations And Accessibility Changes
Data is the single most important thing in a clinical trial. Leverage the power of clinical trial data with effective utilization and access in a changing regulatory landscape.
-
Running Decentralized Trials At Scale
As the industry continues to embrace decentralized approaches, sponsors are recognizing the potential benefits of DCTs, including reduced operational costs and improved recruitment and retention of more diverse patient populations.
-
Compressing Analytical Timelines Without Cutting Corners
Efficient analytical development speeds decisions and improves risk visibility. Using QbD, digital tools, and strong communication helps teams accelerate timelines while maintaining rigor.
-
Choosing RTSM? Evaluate The Team Running It, Not Just The Software
High-performing RTSM requires more than just code. Discover why team continuity and clinical expertise are the most overlooked factors in reducing trial risk and ensuring regulatory compliance.
-
Using IRT Data To Automate And Optimize Clinical Supply
Learn how clinical teams can save between $150,000 and $1 million in annual drug and shipping costs through automated supply optimization.
-
Industry Trends: Clinical Logistics Outsourcing
Understanding industry trends, market dynamics, and the selection criteria decision-makers apply when choosing a clinical logistics service provider informs and contextualizes outsourcing decisions.
-
How Pharmaceutical Manufacturers Can Take Control Of Their Supply Chain
In an increasingly competitive and regulated landscape, the right ERP system is no longer optional—it’s essential to reclaim control and drive growth in pharmaceutical manufacturing.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.